Sunitinib Malate Synergistically Potentiates Anti-Tumor Effect of Gemcitabine in Human Bladder Cancer Cells

PURPOSE: Sunitinib malate (Sutent; Pfizer, New York, NY, USA) is a highly selective multi-targeted agent and has been reported to have potent anti-tumor effects against various tumors, including renal cell carcinoma and gastrointestinal stromal tumors. In this study, we explored in vitro the anti-tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Cheol Yong, Lee, Jung Sun, Kim, Bo Sun, Jeong, Seong Jin, Hong, Sung Kyu, Byun, Seok Soo, Lee, Sang Eun
Formato: Texto
Lenguaje:English
Publicado: The Korean Urological Association 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037508/
https://www.ncbi.nlm.nih.gov/pubmed/21344032
http://dx.doi.org/10.4111/kju.2011.52.1.55

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037508/
https://www.ncbi.nlm.nih.gov/pubmed/21344032
http://dx.doi.org/10.4111/kju.2011.52.1.55

Ejemplares similares